Cargando…

Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer

OBJECTIVE: The maximal standardized uptake value (SUVmax) of pulmonary lesions on dual-time-point (DTP) fluorodeoxyglucose positron emission tomography (FDG-PET) has been shown to be useful for differentiation between malignant and non-malignant pulmonary lesions, and also to be of value for intrath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shimizu, Katsuhiko, Okita, Riki, Saisho, Shinsuke, Yukawa, Takuro, Maeda, Ai, Nojima, Yuji, Nakata, Masao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Japan 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666280/ https://www.ncbi.nlm.nih.gov/pubmed/26254228 http://dx.doi.org/10.1007/s12149-015-1013-3

Ejemplares similares

Lapatinib enhances trastuzumab-mediated antibody-dependent cellular cytotoxicity via upregulation of HER2 in malignant mesothelioma cells
por: OKITA, RIKI, et al.
Publicado: (2015)

Difference in prognostic values of maximal standardized uptake value on fluorodeoxyglucose-positron emission tomography and cyclooxygenase-2 expression between lung adenocarcinoma and squamous cell carcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2014)

Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Prognostic nutritional index before adjuvant chemotherapy predicts chemotherapy compliance and survival among patients with non-small-cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Prognostic value of Cox-2 and PD-L1 expression and its relationship with tumor-infiltrating lymphocytes in resected lung adenocarcinoma
por: Shimizu, Katsuhiko, et al.
Publicado: (2017)

Clinicopathological relevance of tumor expression of NK group 2 member D ligands in resected non-small cell lung cancer
por: Okita, Riki, et al.
Publicado: (2019)

Comparative study of the PD-L1 expression and CD8+ tumor-infiltrating lymphocyte between surgically resected and matched re-biopsy specimens in recurrent non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2019)

Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report
por: Maeda, Ai, et al.
Publicado: (2016)

Preoperative neutrophil/lymphocyte ratio and prognostic nutritional index predict survival in patients with non-small cell lung cancer
por: Shimizu, Katsuhiko, et al.
Publicado: (2015)

Clinicopathological and immunohistochemical features of lung invasive mucinous adenocarcinoma based on computed tomography findings
por: Shimizu, Katsuhiko, et al.
Publicado: (2016)

Influence of vascular endothelial growth factor single nucleotide polymorphisms on non-small cell lung cancer tumor angiogenesis
por: MAEDA, AI, et al.
Publicado: (2012)

A case report of intrapulmonary schwannoma
por: Yukawa, Takuro, et al.
Publicado: (2013)

Tofacitinib overcomes an IFNγ‐induced decrease in NK cell‐mediated cytotoxicity via the regulation of immune‐related molecules in LC‐2/ad
por: Okita, Riki, et al.
Publicado: (2021)

Membrane-bound estrogen receptor-α expression and epidermal growth factor receptor mutation are associated with a poor prognosis in lung adenocarcinoma patients
por: Shimizu, Katsuhiko, et al.
Publicado: (2012)

Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
por: Okita, Riki, et al.
Publicado: (2015)

Utility of dual time point 18 FDG PET-CT
por: De Luca, SE, et al.
Publicado: (2014)

Dual time point based quantification of metabolic uptake rates in (18)F-FDG PET
por: den Hoff, Jörg van, et al.
Publicado: (2013)

The Clinical Role of Dual-Time-Point (18)F-FDG PET/CT in Differential Diagnosis of the Thyroid Incidentaloma
por: Lee, Sinae, et al.
Publicado: (2013)

18-FDG PET in lung transplantation
por: Algieri, I, et al.
Publicado: (2015)

Myocarditis on (18)FDG-PET imaging
por: Chaaban, Nourhan, et al.
Publicado: (2022)

The sensitivity and specificity of (18)F-FDG PET/CT in spinal leptomeningeal metastases: the synergistic effect of the (18)F-FDG PET-CT to gadolinium-enhanced MRI
por: Luo, Zhe-Huang, et al.
Publicado: (2023)

Value of (18)F-FDG PET/MRI in the Preoperative Assessment of Resectable Esophageal Squamous Cell Carcinoma: A Comparison With (18)F-FDG PET/CT, MRI, and Contrast-Enhanced CT
por: Wang, Fei, et al.
Publicado: (2022)

PET probes beyond (18)F-FDG
por: Jiang, Lei, et al.
Publicado: (2014)

Feasibility of (18)FDG PET in the cardiac inflammation
por: Osiecki, Sebastian, et al.
Publicado: (2020)

Measurement Repeatability of (18)F-FDG PET/CT Versus (18)F-FDG PET/MRI in Solid Tumors of the Pelvis
por: Fraum, Tyler J., et al.
Publicado: (2019)

Evaluation of Dual Time Point Imaging 18F-FDG PET/CT in Differentiating Malignancy From Benign Gastric Disease
por: Cui, Jing, et al.
Publicado: (2015)

Comparison of (18)F-FDG PET/CT imaging with different dual time (18)F-FDG PET/CT with forced diuresis in clinical diagnosis of prostate cancer
por: Yu, Longhua, et al.
Publicado: (2023)

(18)F‐FDG PET‐CT in a patient with methotrexate‐associated lymphoproliferative disorder
por: Shimizu, Hayato, et al.
Publicado: (2017)

Dual time point imaging of FDG PET/CT in a tuberculous spondylodiscitis
por: Abdul, HR, et al.
Publicado: (2010)

Anorectal malignant melanoma: curative abdominoperineal resection: patient selection with 18F-FDG-PET/CT
por: Falch, Claudius, et al.
Publicado: (2016)

Early recurrence detected by (18)F-FDG PET/CT in patients with resected pancreatic ductal adenocarcinoma
por: Wang, Li, et al.
Publicado: (2020)

Clinicopathological, Oncogenic, and (18)F-FDG PET/CT Features of Primary Pulmonary Carcinoid in Resection Specimens
por: Chen, Yun, et al.
Publicado: (2022)

18F-FDG PET/MRI and 18F-FDG PET/CT for the Management of Gynecological Malignancies: A Comprehensive Review of the Literature
por: Allahqoli, Leila, et al.
Publicado: (2023)

Dual Tracer 68Ga-DOTATOC and 18F-FDG PET Improve Preoperative Evaluation of Aggressiveness in Resectable Pancreatic Neuroendocrine Neoplasms
por: Mapelli, Paola, et al.
Publicado: (2021)

Dual-time-point F-18 FDG PET/CT imaging for differentiating the lymph nodes between malignant lymphoma and benign lesions
por: Nakayama, Michihiro, et al.
Publicado: (2012)

The role of dual time point PET/CT for distinguishing malignant from benign focal (18)F-FDG uptake duodenal lesions
por: Sa, Ri, et al.
Publicado: (2018)

Diagnostic Superiority of Dual-Time Point [(18)F]FDG PET/CT to Differentiate Malignant from Benign Soft Tissue Tumors
por: d’Abadie, Philippe, et al.
Publicado: (2023)

Detection of Liver Lesions in Colorectal Cancer Patients Using (18)F-FDG PET/CT Dual-Time-Point Scan Imaging
por: Boanova, Luciane G., et al.
Publicado: (2023)

Quantitative techniques in (18)FDG PET scanning in oncology
por: Castell, F, et al.
Publicado: (2008)

(18)F-FDG PET/CT Imaging In Oncology
por: Almuhaideb, Ahmad, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_j1r2iltut7o8io3kh6cm3vfubq